West shifts focus to proprietary products
West Pharmaceutical is changing its gauge from contract manufacturing to proprietary products: it’s particular focus, delivery systems.
Archives for May 22, 2012
US Senate votes on FDA safety and innovation act
The US FDA will have more powers to inspect ‘risky’ overseas pharmaceutical plants according to supporters of a bill being considered by the US senate this week.